Atrial fibrillation with flutter episode in patient with mitral stenosis
Abstract
Mitral stenosis (MS) is a condition which happened because of congenital or acquired event. The most common etiology of MS in Indonesia is Rheumatic Heart Disease (RHD). Chronic inflammation on the mitral valve could lead to stenosis from mild to severe degree. Mitral stenosis could lead to many complications such as pulmonary hypertension and atrial fibrillation (AF). The prevalence of AF in patients with MS is related to the severity of valve obstruction and patient age. AF event in patient with MS could be happen because of Left Atrial (LA) dilatation of the patient. The mechanism that responsible for AF in patient with MS is a complex one. AF even with or without atrial flutter episode could lead a deterioration of patient hemodynamic. In the other way, the patient also predisposes to left atrial thrombus formation and systemic embolic events. Good awareness in diagnosis and management of atrial fibrillation in patient with MS are mandatory to reduce the morbidity and mortality.
Keywords
Full Text:
PDFReferences
Otto CM, Bonow R. 2015. Valvular Heart Disease. In: Mann D, Zipes D, Libby P, Bonow R, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th Edition. Philadelphia: Elsevier; 2015. P.1446-1480.
Prystowsky EN, Padanilam BJ, Waldo AL. Atrial Fibrillation, Atrial Flutter, and Atrial Tachycardia. In: Fuster V, Walsh RA, Harrington RA, eds. Hurst's The Heart. New York: The McGraw-Hill Companies; 2011. P.963-987.
Rodriguez L, Gillinov AM. Mitral Valve Disease. In: Topol EJ, Califf RM, eds. Textbook of Cardiovascular Medicine. 3rd Edition. Ohio: Lippincott Williams & Wilkins; 2007. P.346-363.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for The Management of Atrial Fibrillation Developed in Collaboration with EACTS. European Heart Journal. 2016; 37(38):2893–2962. doi: 10.1093/eurheartj/ehw210.
Joint Task Force on the Management of Varvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, et al. Guidelines on the management of valvular heart disease (version 2012). European Heart Journal. 2012; 33(19):2451–2496. doi: 10.1093/eurheartj/ehs109.
Constant J. The Opening Snap. In: Constant J, ed. Essentials of Bedside Cardiology. 2nd Edition. New Jersey: Humana Press; 2003. P.155-165.
Jung H, Lilly LS. 2011. The Cardiac Cycle: Mechanisms of Heart Sounds and Murmur. In: Lilly LS, ed. Pathophysiology of Heart Disease. Massachusetts: Lippincott Williams & Wilkins; 2011. P.35-36.
Ranganathan N, Sivaciyan V, Saksena FB. Heart Sounds. In: Ranganathan N, Sivaciyan V, Saksena FB, eds. The Art and Science of Cardiac Physical Examination. 2nd Edition. New Delhi: The Health Sciences Publisher; 2016; P.220-233.
Morady F, Zipes D. Atrial Fibrillation: Clinical Features, Mechanisms, and Management. In: Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th Edition. Philadelphia: Saunders; 2015. P.798-820.
Hu R, Stevenson WG, Lilly LS. Clinical Aspects of Cardiac Arrhythmias. In: Lilly LS, ed. Pathophysiology of Heart Diseases. Massachusetts: Lippincott Williams & Wilkins; 2011. P.284-301.
Omran AS, Arifi AA, Mohamed AA. 2011. Echocardiography in Mitral Stenosis. Journal of the Saudi Heart Association. 2011; 23(1): 51–58. doi: 10.1016/j.jsha.2010.07.007.
Nobuyoshi M, Arita T, Shirai S, Hamasaki N, Yokoi H, Iwabuchi M, et al. Percutaneous Ballon Mitral Valvuloplasty. Circulation. 2008; 119:e211-219. doi: 10.1161/CIRCULATIONAHA.108.792952.
Nunes MC, Tan TC, Elmariah S, do Lago R, Margey R, Cruz-Gonzalez I, et al. Impact of Incorporating Commisural Morphology and Leaflet Displacement to the Prediction of Outcome for Patients Undergoing Percutaneous Mitral Valvuloplasty. Circulation. 2014; 129(8):886-895. doi: 10.1161/CIRCULATIONAHA.113.001252.
Andrade J, Khairy P, Dobrev D, Nattel S. The Clinical Profile and Pathophysiology of Atrial Fibrillation: Relationships Among Clinical Features, Epidemiology, and Mechanisms. Circ Res. 2014; 114(9):1453-1468. doi: 10.1161/CIRCRESAHA.114.303211.
Fox KA, White HD, Gersh BJ, Opie LH. Antithrombotic Agents: Platelet Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, eds. Drugs for The Heart. 8th Edition. Philadelphia: Saunders; 2013. P.332-367.
